Literature DB >> 25829230

Personality and breast cancer risk and survival: the Miyagi cohort study.

Yuko Minami1, Toru Hosokawa, Naoki Nakaya, Yumi Sugawara, Yoshikazu Nishino, Yoichiro Kakugawa, Akira Fukao, Ichiro Tsuji.   

Abstract

It has long been hypothesized that personality is associated with breast cancer risk and survival. The present population-based prospective cohort study in Japan tested this hypothesis. To investigate the association of personality with breast cancer risk, a total of 15,107 women aged 40-64 years who completed the Eysenck Personality Questionnaire-Revised (EPQ-R) Short Form were followed from 1990 to 2007. To assess the association of personality with survival after breast cancer, 250 identified cases were further followed up from the date of diagnosis to 2008, and 45 all-cause deaths were documented. Study subjects were categorized into four groups based on the quartile points of scores ranging between 0 and 12 on each EPQ-R subscale (extraversion, neuroticism, psychoticism, and lie), and the hazard ratio (HR) for each category was computed using the lowest category as reference. Multivariate analysis revealed no association between any of the four personality subscales and the risk of breast cancer. In the analysis on survival, no significant association was found between any of these subscales and the risk of death, although breast cancer cases with a higher score of extraversion tended to have a lower risk of death (P for trend = 0.07; HR for highest score level = 0.38). Exclusion of 32 cases diagnosed in the first 3 years of follow-up did not largely change the results with regard to either breast cancer risk or survival. The present findings suggest that personality does not impact significantly on the development and progression of breast cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25829230     DOI: 10.1007/s10549-015-3364-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  The impact of personality traits on pessary treatment outcomes in patients with pelvic organ prolapse.

Authors:  Congcong Ma; Jia Kang; Tao Xu; Ye Zhang; Yidi Ma; Lan Zhu
Journal:  Int Urogynecol J       Date:  2020-11-18       Impact factor: 2.894

Review 2.  A conceptual model of social networks and mechanisms of cancer mortality, and potential strategies to improve survival.

Authors:  Candyce H Kroenke
Journal:  Transl Behav Med       Date:  2018-07-17       Impact factor: 3.046

3.  Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.

Authors:  Yuko Minami; Seiki Kanemura; Masaaki Kawai; Yoshikazu Nishino; Hiroshi Tada; Minoru Miyashita; Takanori Ishida; Yoichiro Kakugawa
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

4.  Causal Attributions in Breast Cancer Patients Planning to Undergo Adjuvant Endocrine Therapy.

Authors:  Seul Ki Park; Yul Ha Min; Minsun Lee; Sae Byul Lee
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390

5.  iTRAQ-based quantitative proteomic analysis provides insight for molecular mechanism of neuroticism.

Authors:  Lei Tian; Hong-Zhao You; Hao Wu; Yu Wei; Min Zheng; Lei He; Jin-Ying Liu; Shu-Zhen Guo; Yan Zhao; Ren-Lai Zhou; Xingang Hu
Journal:  Clin Proteomics       Date:  2019-11-08       Impact factor: 3.988

6.  Type D Personality and Big Five Personality Traits and the Risk of Breast Cancer: A Case-Control Study.

Authors:  Irena Wojciechowska; Rafał Matkowski; Tomasz Pawłowski
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

7.  Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer.

Authors:  Filiz İzci; Dauren Sarsanov; Zeynep İyigün Erdogan; Ahmet Serkan İlgün; Esra Çelebi; Gül Alço; Nazmiye Kocaman; Çetin Ordu; Alper Öztürk; Tomris Duymaz; Kezban Nur Pilavcı; Filiz Elbüken; Filiz Ağaçayak; Fatma Aktepe; Gizem Ünveren; Gözdem Özdem; Yeşim Eralp; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2018-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.